Reply: Comment on 'Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma'

[1]  D. McMillan,et al.  Comment on ‘Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma' , 2013, British Journal of Cancer.

[2]  R. Palmqvist,et al.  The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer , 2012, PloS one.

[3]  R. Bloigu,et al.  Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma , 2012, British Journal of Cancer.

[4]  Zhi-ren Zhang,et al.  Macrophages in Tumor Microenvironments and the Progression of Tumors , 2012, Clinical & developmental immunology.

[5]  P. Pauwels,et al.  Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy , 2011, Clinical & developmental immunology.

[6]  T. Fry,et al.  Harnessing the biology of IL-7 for therapeutic application , 2011, Nature Reviews Immunology.

[7]  Giacomo Puppa,et al.  TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. , 2010, Archives of pathology & laboratory medicine.

[8]  D. McMillan,et al.  Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. , 2010, Future oncology.

[9]  V. Colantuoni,et al.  Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome. , 2009, Human pathology.

[10]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[11]  J. Melkko,et al.  Inflammation and prognosis in colorectal cancer. , 2005, European journal of cancer.

[12]  C. Ko,et al.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.

[13]  V. Kosma,et al.  Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer , 1997, The Journal of pathology.

[14]  C. Casciani,et al.  Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression , 1996, Cancer Immunology, Immunotherapy.

[15]  P. Leder,et al.  IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo , 1993, The Journal of experimental medicine.